APAIIF 亞太人工智能產業總會APAIIFAI Knowledge
AI in Healthcare

Mass General Brigham AI Virtual Primary Care: 77% of 36,000 Patients Get Same-Day Physician Access, K Health Partnership Reshapes Healthcare Accessibility

October 21, 20266 Views
Mass General Brigham AI Virtual Primary Care: 77% of 36,000 Patients Get Same-Day Physician Access, K Health Partnership Reshapes Healthcare Accessibility
AI醫療
虛擬初級護理
Mass General Brigham
醫療可及性
AI代理問診

Mass General Brigham AI Virtual Primary Care: 77% of 36,000 Patients Get Same-Day Physician Access

Background: The Urgency of the Primary Care Crisis

The United States faces a severe primary care physician shortage crisis. According to the American Medical Association (AMA) 2026 survey, while 81% of physicians now use AI in their daily practice, the fundamental problem of the healthcare system — insufficient physician numbers and excessive patient wait times — remains the core bottleneck constraining healthcare accessibility.

Against this backdrop, Mass General Brigham (MGB) — one of America's most prestigious healthcare systems — partnered with AI healthcare technology company K Health to launch the MGB Care Connect platform, offering a remarkable solution.

MGB Care Connect: AI-Driven Virtual Primary Care

Platform Overview

MGB Care Connect is a virtual primary care pathway integrated into the existing patient portal (Epic MyChart). Patients don't need to download a new application — they can access AI-driven healthcare services directly through the familiar Epic MyChart interface.

This "seamless integration" design philosophy significantly lowers the barrier for patients to adopt new technology, and is one of the key reasons MGB Care Connect was able to serve 36,000 patients in its first year.

Core Functions of the AI Agent

When a patient initiates a visit request, the AI agent executes a complete clinical intake process:

Symptom Collection and Analysis The AI agent simulates human clinical intake interviews, systematically collecting the patient's symptom descriptions, medical history, medications, and allergy information. Unlike traditional questionnaire completion, the AI agent can dynamically adjust follow-up questions based on patient responses, ensuring the most relevant clinical information is collected.

Care Level Triage Based on intake results, the AI agent automatically determines the appropriate level of care:

  • Virtual urgent care (for acute symptoms)
  • Virtual doctor appointment (for non-urgent issues)
  • Referral to in-person visit (for situations requiring physical examination)

Pre-Populated Clinical Notes One of the AI agent's most important functions is generating pre-populated clinical notes before physician involvement. These notes integrate:

  • Symptom information collected during AI intake
  • Relevant medical history extracted from the Electronic Health Record (EHR)
  • Preliminary differential diagnosis suggestions

By the time the physician begins interacting with the patient, most information gathering is already complete, allowing physicians to dedicate more time and energy to clinical decision-making and patient communication.

Key Performance Data

First-Year Operational Results

MGB Care Connect achieved impressive results in its first year of operation:

Metric Data
Total patients served 36,000
Same-day physician access rate 77%
Daily visit volume ~150
Operating period ~1 year (as of September 2026)

The 77% same-day visit rate is the most striking of these figures. In traditional primary care models, patients typically wait days or even weeks to schedule a physician appointment. MGB Care Connect compresses this wait time to the same day, representing a fundamental improvement in healthcare accessibility.

Impact on Physician Efficiency

The pre-populated notes feature also significantly improves physician efficiency. According to MGB's reports, AI agent-generated notes enable physicians to:

  • Reduce intake time, dedicating more time to clinical decision-making
  • See more patients in the same amount of time
  • Reduce the cognitive burden of documentation, alleviating professional burnout

Technical Architecture: K Health's AI Intake Engine

K Health is the core technology provider for MGB Care Connect. Its AI intake engine, based on deep learning from millions of real medical interactions, can:

Natural Language Understanding: Accurately understand symptoms described by patients in non-medical terminology and map them to standardized clinical concepts.

Dynamic Intake Logic: Adjust the intake pathway in real-time based on patient responses, simulating the thought process of an experienced clinician.

EHR Integration: Deep integration with the Epic system to automatically extract patients' historical medical records, medication records, and allergy information, avoiding redundant collection.

Multilingual Support: Support for multiple languages beyond English, improving service accessibility for non-English-speaking patients.

Governance Challenges: Balancing Safety and Trust

MGB's leadership has candidly addressed the challenges associated with promoting AI medical tools.

Data Security

MGB Chief Information and Digital Officer Jane Moran emphasized that data security is the primary consideration for AI medical applications. MGB Care Connect employs strict data encryption and access control measures to ensure patient health information is not accessed without authorization.

AI Hallucination Risk

One of the greatest technical challenges facing AI intake systems is the "hallucination" problem — AI may generate seemingly plausible but actually inaccurate clinical information. MGB mitigates this risk through:

  • All AI-generated notes require physician review and confirmation
  • The system is designed as an assistive tool rather than a replacement for physician decision-making
  • Continuous monitoring of AI output accuracy with ongoing model optimization

Public Trust

Data from Ohio State University Wexner Medical Center shows public openness to healthcare AI dropped from 52% in 2024 to 42% by April 2026. MGB's response strategy emphasizes AI as "augmented intelligence" rather than "replacing physicians," ensuring patients always interact with real physicians.

Lessons for the Asia-Pacific Region

The success of MGB Care Connect holds important lessons for the Asia-Pacific region. Asia-Pacific faces similar challenges of unequal healthcare resource distribution:

Urban-Rural Gap: In China, India, Southeast Asia, and other regions, rural areas face severe healthcare resource shortages. AI virtual primary care can effectively bridge this gap.

Physician Shortage: Multiple Asia-Pacific countries face physician shortages. AI agent intake can improve the service efficiency of existing physicians.

Linguistic Diversity: Asia-Pacific's linguistic diversity makes AI multilingual intake capability particularly important for improving healthcare accessibility.

Healthcare systems in Hong Kong, Singapore, and other locations have begun exploring similar AI virtual care models, and MGB Care Connect's data provides strong empirical support for these explorations.

Future Outlook

MGB plans to further expand AI applications in the healthcare system based on MGB Care Connect's success:

  • Chronic Disease Management: Using AI agents to continuously monitor chronic disease patients' health status, proactively identifying early warning signs of deterioration
  • Preventive Care: Proactively pushing personalized preventive care recommendations based on patient health data and risk factors
  • Multi-Specialty Coordination: In complex cases, AI agents coordinate opinions from multiple specialists to provide integrated care plans

Conclusion: A New Standard for AI Healthcare

The success of MGB Care Connect is not just a technology case study but a new standard for AI healthcare applications. The 77% same-day visit rate, the scale of 36,000 patients served, and the significant improvement in physician efficiency together demonstrate the enormous potential of AI agents in addressing healthcare accessibility challenges.

Against the backdrop of globally strained healthcare systems, MGB Care Connect provides not just a technical solution but a replicable healthcare service model — through AI agent intelligent intake and triage, maximizing the effectiveness of limited healthcare resources.

FAQ

Related Articles

Aidoc AI Radiology Foundation Model: 2,000 Hospitals, 60 Million Annual Cases, FDA Clearance for 14 CT Triage Conditions, Radiology AI Enters Scale Era
AI in Healthcare

Aidoc AI Radiology Foundation Model: 2,000 Hospitals, 60 Million Annual Cases, FDA Clearance for 14 CT Triage Conditions, Radiology AI Enters Scale Era

Aidoc's AI radiology platform covers nearly 2,000 hospitals processing 60 million annual cases, receiving FDA clearance in January 2026 for a foundation model CT triage solution covering 14 clinical conditions. Radiology AI accounts for 76% of all FDA AI medical device clearances as the industry enters a new era of scaled deployment.

Nov 2, 202612
AI Ambient Scribe Clinical Evidence: 2.3 Million Encounters Show 31% Physician Burnout Reduction, 2x ROI in 14 Months
AI in Healthcare

AI Ambient Scribe Clinical Evidence: 2.3 Million Encounters Show 31% Physician Burnout Reduction, 2x ROI in 14 Months

Multiple large-scale 2026 clinical studies confirm AI ambient scribe benefits: 2.3 million encounter data shows physician burnout dropping from 51.9% to 38.8% (31% reduction), 13-16 minutes saved per shift, 87-89% semantic accuracy, and 2x+ ROI within 14 months, though research notes time savings are often reinvested into patient interaction rather than reduced work hours.

Nov 1, 202614
Stanford SIMCO AI Framework Breakthrough: Aspirin-Lansoprazole Combination 15× More Effective Than Aspirin Alone for Preterm Birth Prevention, Now in Clinical Trial
AI in Healthcare

Stanford SIMCO AI Framework Breakthrough: Aspirin-Lansoprazole Combination 15× More Effective Than Aspirin Alone for Preterm Birth Prevention, Now in Clinical Trial

Stanford's SIMCO AI framework, simulating 218 million immune cells, discovered that the aspirin-lansoprazole (SALPZ) combination is 15× more effective than aspirin alone at preventing preterm birth, with a median 17.3-day labor delay and 87.3% responder rate. FDA has authorized a 670-patient clinical trial.

Oct 31, 202611